Q3 2024 13F Holders as of 30 Sep 2024
-
Type / Class
-
Equity / Common Shares, par value $0.0000000341740141 per share
-
Shares outstanding
-
695,088,397
-
Total 13F shares
-
564,717,839
-
Share change
-
+13,780,990
-
Total reported value
-
$6,516,467,949
-
Put/Call ratio
-
199%
-
Price per share
-
$11.54
-
Number of holders
-
294
-
Value change
-
+$176,659,948
-
Number of buys
-
169
-
Number of sells
-
123
Institutional Holders of Roivant Sciences Ltd. - Common Shares, par value $0.0000000341740141 per share (ROIV) as of Q3 2024
As of 30 Sep 2024,
Roivant Sciences Ltd. - Common Shares, par value $0.0000000341740141 per share (ROIV) was held by
294 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
564,717,839 shares.
The largest 10 holders included
SB INVESTMENT ADVISERS (UK) LTD, QVT Financial LP, VIKING GLOBAL INVESTORS LP, FMR LLC, BlackRock, Inc., VANGUARD GROUP INC, MORGAN STANLEY, Rubric Capital Management LP, STATE STREET CORP, and Patient Square Capital LP.
This page lists
291
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.